JP2015529633A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015529633A5 JP2015529633A5 JP2015517672A JP2015517672A JP2015529633A5 JP 2015529633 A5 JP2015529633 A5 JP 2015529633A5 JP 2015517672 A JP2015517672 A JP 2015517672A JP 2015517672 A JP2015517672 A JP 2015517672A JP 2015529633 A5 JP2015529633 A5 JP 2015529633A5
- Authority
- JP
- Japan
- Prior art keywords
- bag3
- biological sample
- antibody
- urine
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 7
- 239000012472 biological sample Substances 0.000 claims 6
- 102100027954 BAG family molecular chaperone regulator 3 Human genes 0.000 claims 5
- 101000697871 Homo sapiens BAG family molecular chaperone regulator 3 Proteins 0.000 claims 5
- 210000002381 plasma Anatomy 0.000 claims 4
- 210000003296 saliva Anatomy 0.000 claims 4
- 210000002966 serum Anatomy 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 4
- 238000008157 ELISA kit Methods 0.000 claims 3
- 208000019622 heart disease Diseases 0.000 claims 3
- 206010061218 Inflammation Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 201000010235 heart cancer Diseases 0.000 claims 1
- 208000024348 heart neoplasm Diseases 0.000 claims 1
- 230000000642 iatrogenic effect Effects 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12172531.1A EP2676966A1 (en) | 2012-06-19 | 2012-06-19 | BAG3 as biochemical serum and tissue marker |
| EP12172531.1 | 2012-06-19 | ||
| PCT/EP2013/061976 WO2013189778A1 (en) | 2012-06-19 | 2013-06-11 | Bag3 as biochemical serum and tissue marker |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015529633A JP2015529633A (ja) | 2015-10-08 |
| JP2015529633A5 true JP2015529633A5 (enExample) | 2016-07-28 |
| JP6654432B2 JP6654432B2 (ja) | 2020-02-26 |
Family
ID=48607259
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015517672A Expired - Fee Related JP6654432B2 (ja) | 2012-06-19 | 2013-06-11 | 生化学的血清マーカーおよび組織マーカーとしてのｂａｇ３ |
| JP2015517669A Pending JP2015521475A (ja) | 2012-06-19 | 2013-06-11 | 生化学的血清マーカーおよび組織マーカーとしてのｂａｇ３ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015517669A Pending JP2015521475A (ja) | 2012-06-19 | 2013-06-11 | 生化学的血清マーカーおよび組織マーカーとしてのｂａｇ３ |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20150132764A1 (enExample) |
| EP (3) | EP2676966A1 (enExample) |
| JP (2) | JP6654432B2 (enExample) |
| KR (2) | KR20150036102A (enExample) |
| CN (2) | CN104507965B (enExample) |
| AU (2) | AU2013279604B2 (enExample) |
| BR (2) | BR112014031958A2 (enExample) |
| CA (2) | CA2876872A1 (enExample) |
| ES (1) | ES2795981T3 (enExample) |
| IN (2) | IN2014DN10562A (enExample) |
| PL (1) | PL2861618T3 (enExample) |
| WO (2) | WO2013189775A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20130403A1 (it) | 2013-03-18 | 2014-09-19 | Biouniversa Srl | Anticorpi anti-bag3 per uso terapeutico |
| CN105021825B (zh) * | 2015-07-09 | 2016-08-17 | 陈勇 | 一种检测胰腺癌相关多肽dap44的elisa试剂盒 |
| CN105769900A (zh) * | 2016-03-22 | 2016-07-20 | 山西大学 | Bag3基因在制备抗膀胱癌药物中的应用 |
| IT201600069391A1 (it) * | 2016-07-04 | 2016-10-04 | Univ Degli Studi Di Salerno | Uso della proteina bag3 e suoi frammenti peptidici per il controllo dell’omeostasi vascolare |
| WO2021140173A1 (en) | 2020-01-10 | 2021-07-15 | Biouniversa S.R.L. | Methods and uses for treating fibrotic solid tumors with bags inhibitors |
| US11940450B2 (en) | 2021-03-16 | 2024-03-26 | University Of Connecticut | Biomarker panel for non-invasive diagnosis of congenital renal dysfunction |
| CN113862361B (zh) * | 2021-10-25 | 2023-08-15 | 中山大学孙逸仙纪念医院 | 一种诊断和治疗膀胱癌的分子标志物hsf1及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652223A (en) * | 1994-03-14 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | DNA encoding CAI resistance proteins and uses thereof |
| AU5789500A (en) * | 1999-07-09 | 2001-01-30 | Burnham Institute, The | A method for determining the prognosis of cancer patients by measuring levels ofbag expression |
| US20030073623A1 (en) | 2001-07-30 | 2003-04-17 | Drmanac Radoje T. | Novel nucleic acid sequences obtained from various cDNA libraries |
| EP2131198B1 (en) * | 2001-09-20 | 2013-03-27 | Board of Regents, The University of Texas System | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| EP1323733A1 (en) * | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| US20090047689A1 (en) * | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
| WO2011044927A1 (en) * | 2009-10-12 | 2011-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for the diagnosis or prognosis of an advanced heart failure |
| IT1397083B1 (it) * | 2009-12-04 | 2012-12-28 | Biouniversa Srl | Marcatore biochimico serico |
| GB201017520D0 (en) * | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
-
2012
- 2012-06-19 EP EP12172531.1A patent/EP2676966A1/en not_active Withdrawn
-
2013
- 2013-06-11 ES ES13728180T patent/ES2795981T3/es active Active
- 2013-06-11 KR KR20157001228A patent/KR20150036102A/ko not_active Withdrawn
- 2013-06-11 JP JP2015517672A patent/JP6654432B2/ja not_active Expired - Fee Related
- 2013-06-11 AU AU2013279604A patent/AU2013279604B2/en not_active Ceased
- 2013-06-11 WO PCT/EP2013/061971 patent/WO2013189775A1/en not_active Ceased
- 2013-06-11 BR BR112014031958A patent/BR112014031958A2/pt not_active IP Right Cessation
- 2013-06-11 AU AU2013279601A patent/AU2013279601A1/en not_active Abandoned
- 2013-06-11 CA CA2876872A patent/CA2876872A1/en not_active Abandoned
- 2013-06-11 CA CA2876922A patent/CA2876922C/en active Active
- 2013-06-11 WO PCT/EP2013/061976 patent/WO2013189778A1/en not_active Ceased
- 2013-06-11 PL PL13728180T patent/PL2861618T3/pl unknown
- 2013-06-11 BR BR112014031957A patent/BR112014031957A2/pt not_active IP Right Cessation
- 2013-06-11 EP EP13728375.0A patent/EP2861754A1/en not_active Ceased
- 2013-06-11 JP JP2015517669A patent/JP2015521475A/ja active Pending
- 2013-06-11 EP EP13728180.4A patent/EP2861618B1/en active Active
- 2013-06-11 CN CN201380032138.3A patent/CN104507965B/zh not_active Expired - Fee Related
- 2013-06-11 KR KR1020157001313A patent/KR102150903B1/ko not_active Expired - Fee Related
- 2013-06-11 CN CN201380032196.6A patent/CN104619861A/zh active Pending
-
2014
- 2014-12-11 IN IN10562DEN2014 patent/IN2014DN10562A/en unknown
- 2014-12-11 IN IN10561DEN2014 patent/IN2014DN10561A/en unknown
- 2014-12-16 US US14/572,445 patent/US20150132764A1/en not_active Abandoned
- 2014-12-16 US US14/572,654 patent/US10359433B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015529633A5 (enExample) | ||
| Meijers et al. | Heart failure stimulates tumor growth by circulating factors | |
| Jia et al. | In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography | |
| Wu | Release of cardiac troponin from healthy and damaged myocardium | |
| EA201070738A1 (ru) | Композиции и способы детекции tiab | |
| BRPI1007867B8 (pt) | anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente | |
| JP2016513094A5 (enExample) | ||
| WO2013068374A3 (en) | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment | |
| EA201792497A1 (ru) | Антитела к gitr для диагностики злокачественной опухоли | |
| Sasaki et al. | Left atrial strain as evaluated by two-dimensional speckle tracking predicts left atrial appendage dysfunction in patients with acute ischemic stroke | |
| HK1202157A1 (en) | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment | |
| JP2014144959A5 (enExample) | ||
| Gruden et al. | Serum heat shock protein 27 levels in patients with hepatocellular carcinoma | |
| Chen et al. | Association of serum angiopoietin‑1, angiopoietin‑2 and angiopoietin‑2 to angiopoietin‑1 ratio with heart failure in patients with acute myocardial infarction | |
| Wen et al. | Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease | |
| Cardinale et al. | Role of biomarkers in cardioncology. | |
| Villacorta et al. | Prognostic value of plasma neutrophil gelatinase-associated lipocalin in patients with heart failure | |
| WO2014167969A1 (ja) | 大腸がんの検出方法 | |
| Ochiumi et al. | Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation | |
| Schmid et al. | ST2 predicts survival in patients undergoing transcatheter aortic valve implantation | |
| Kim et al. | Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach | |
| Nyström et al. | Type IV collagen as a tumour marker for colorectal liver metastases | |
| RU2670052C1 (ru) | Антигенный полипептид для выявления в плазме крови иммунного маркера - аутоантитела к vegfr1 и его применение | |
| Iversen et al. | Pregnancy associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque | |
| CN107255711B (zh) | 骨桥蛋白用于制备或筛选慢加急性肝衰竭诊断试剂的用途 |